KR900002778A - 학습력 또는 기억력 증진제 - Google Patents

학습력 또는 기억력 증진제 Download PDF

Info

Publication number
KR900002778A
KR900002778A KR1019890011229A KR890011229A KR900002778A KR 900002778 A KR900002778 A KR 900002778A KR 1019890011229 A KR1019890011229 A KR 1019890011229A KR 890011229 A KR890011229 A KR 890011229A KR 900002778 A KR900002778 A KR 900002778A
Authority
KR
South Korea
Prior art keywords
learning
alkyl
memory
chloro
amino
Prior art date
Application number
KR1019890011229A
Other languages
English (en)
Inventor
존 네일러 로버트
네일러 브렌다
르노 알랭
랑르와 미쉘
Original Assignee
에이.에이취.로빈스 캄퍼니, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이.에이취.로빈스 캄퍼니, 인코포레이티드 filed Critical 에이.에이취.로빈스 캄퍼니, 인코포레이티드
Publication of KR900002778A publication Critical patent/KR900002778A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

학습력 또는 기억력 증진제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1 도는 마우스가 흑색 구획으로부터 백색 구획으로 이동하는데 걸리는 시간을 단축시키는데 대한 시험 화합물의 효과를 나타낸 도표,
제 2 도는 흑색 구역에서 보내는 시간을 연장시키는데 대한 시험 화합물의 효과를 나타낸 도표,
제 3 도는 앞발을 들고 서는 행위의 횟수로서 표시된, 시험 동물에 대한 시험 화합물의 효과를 나타낸 도표.

Claims (4)

  1. 하기 일반식(Ⅰ)의 화합물 또는 그의 N-산화물 및/또는 약학적으로 허용가능한 그의 염을 포함하는, 학습력 또는 기억령을 증진시키기 위한 약제 :
    상기식에서, X는 산소 또는 황이고 ; R1및 R3은 각각 독립적으로 수소 또는 C1-C4알킬키이며 ; Ar은 1내지 3개의 C1-C4알콕시기 및/또는 1 또는 2개의 할로겐 원자에 의해 임의적으로 치환된 페닐고리 ;
    일반식의 페닐고리 ; 또는
    일반식의 피리미딘일 잔기이고 ; R2는 할로겐, 4,5-벤조, C1-C8알콕시, C1-C4알킬카르보닐, 또는 Am (여기서 Am은 아미노, 메틸아미노 또는 디메틸아미노임)이며 ; R4는 C1-C8알킬이고 ; n은 1 또는 2이고 ; R5는 C1-C4알킬이다.
  2. 제 1 항에 있어서, R1및 R3이 각각 독립적으로 수소, 메틸 또는 에틸인 약제.
  3. 제 1 항 또는 제 2 항에 있어서, Ar이 4-Am-5-클로로-2-메톡시페닐인 약제.
  4. R(＋)-4-아미노-N-(1-아자비시클로[2.2.2]옥트-3-일)-5-클로로-2-메톡시벤조아미드 또는 그의 염을 포함하는, 학습력 또는 기억력을 증진시키기 위한 약제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890011229A 1988-08-04 1989-08-04 학습력 또는 기억력 증진제 KR900002778A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88402041A EP0353371A1 (en) 1988-08-04 1988-08-04 Memory enhancing-R-N-(1-azabicyclo[2.2.2] oct-3-yl) benzamides and thiobenzamides
US88402041.3 1988-08-04

Publications (1)

Publication Number Publication Date
KR900002778A true KR900002778A (ko) 1990-03-23

Family

ID=8200414

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890011229A KR900002778A (ko) 1988-08-04 1989-08-04 학습력 또는 기억력 증진제

Country Status (10)

Country Link
US (1) US5017580A (ko)
EP (1) EP0353371A1 (ko)
JP (1) JPH02256616A (ko)
KR (1) KR900002778A (ko)
AU (1) AU624402B2 (ko)
CA (1) CA1333154C (ko)
DK (1) DK381889A (ko)
PH (1) PH25427A (ko)
PT (1) PT91346B (ko)
ZA (1) ZA895797B (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3878235T2 (de) * 1988-08-04 1993-06-03 Synthelabo Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.
EP0527249B1 (en) * 1991-08-09 1997-12-17 Nec Corporation Carrier recovery apparatus for digital satellite communication system
US5273972A (en) * 1992-03-26 1993-12-28 A. H. Robins Company, Incorporated [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6479510B2 (en) 2000-08-18 2002-11-12 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002016357A2 (en) * 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
AU2001284645A1 (en) * 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
US6599916B2 (en) 2000-08-21 2003-07-29 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
PE20021019A1 (es) * 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
EP1419162A1 (en) * 2001-08-24 2004-05-19 Pharmacia & Upjohn Company Substituted-aryl 7-aza 2.2.1]bicycloheptanes for the treatment of disease
AU2002339810A1 (en) * 2001-10-16 2003-04-28 Astrazeneca Ab Azabicyclic compounds for the treatment of fibromyalgia syndrome
US6919359B2 (en) * 2001-11-08 2005-07-19 Pfizer Inc Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
BR0307714A (pt) * 2002-02-15 2005-02-09 Upjohn Co Benzoilamidas substituìdas com azabiciclo e tioamidas para tratamento de distúrbios relacionados ao cns
US7001900B2 (en) 2002-02-20 2006-02-21 Pfizer Inc. Azabicyclic compounds for the treatment of disease
EP1542999A1 (en) 2002-08-01 2005-06-22 Pharmacia & Upjohn Company LLC 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
GB0310867D0 (en) 2003-05-12 2003-06-18 Novartis Ag Organic compounds
EP2344636B1 (en) 2008-10-09 2017-12-06 Howard Hughes Medical Institute Novel chimeric ligand-gated ion channels and methods of use thereof
ES2541528T3 (es) 2008-11-19 2015-07-21 Forum Pharmaceuticals Inc. Tratamiento de trastornos cognitivos con (R)-7-cloro-N-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma
SI3029039T1 (en) 2010-05-17 2018-04-30 Forum Pharmaceuticals Inc. Pharmaceutical formulations containing crystalline forms of (R) -7-chloro-N- (quinuclidin-3-yl) benzo (b) thiophene-2-carboxamide hydrochloride monohydrate
WO2013169646A1 (en) 2012-05-08 2013-11-14 Envivo Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function
CN104418851A (zh) * 2013-09-02 2015-03-18 上海龙翔生物医药开发有限公司 奎宁环衍生物的制备方法及纯化方法
US10370369B2 (en) * 2015-03-31 2019-08-06 Yuki Gosei Kogyo Co. Ltd. Acid addition salt of 3-aminoquinuclidine which does not exhibit deliquescence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
DE3878235T2 (de) * 1988-08-04 1993-06-03 Synthelabo Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.

Also Published As

Publication number Publication date
US5017580A (en) 1991-05-21
EP0353371A1 (en) 1990-02-07
ZA895797B (en) 1991-03-27
AU624402B2 (en) 1992-06-11
PT91346B (pt) 1995-07-03
PT91346A (pt) 1990-03-08
AU3917489A (en) 1990-02-08
CA1333154C (en) 1994-11-22
DK381889A (da) 1990-02-05
JPH02256616A (ja) 1990-10-17
DK381889D0 (da) 1989-08-03
PH25427A (en) 1991-07-01

Similar Documents

Publication Publication Date Title
KR900002778A (ko) 학습력 또는 기억력 증진제
KR950000728A (ko) 포스포네이트 뉴클레오티드 에스테르 유도체
KR940007022A (ko) 피패리딘 유도체, 이것의 제법 및 치료에 있어서 이것의 이용
KR920002596A (ko) 아지비사이클로 유도체
KR960004344A (ko) 6원 질소 함유 헤테로아릴-옥사졸리디논
KR920702360A (ko) 인돌 유도체
KR920021517A (ko) 중축 신경계에 활성인 신규의 3-아미노피리다진 유도체, 그의 제조방법 및 이들의 존재하는 약제학적 조성물
KR890011902A (ko) 디데옥시디데히드로카르보시클릭 뉴클레오시드
KR900002777A (ko) 정신분열증 및 정신병 치료 또는 예방제
KR880013937A (ko) 옥세타노신 유도체
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
KR930016402A (ko) 항-hiv 활성을 갖는 이미다졸 유도체
KR890014107A (ko) 백금 화학 요법약제
KR920701120A (ko) 치환된 비시클로헵탄디온 유도체
SE8305157D0 (sv) Biologiskt aktiva 2,5-piperazindionderivat, sett for framstellning derav samt farmaceutiska kompositioner innehallande desamma
KR920007995A (ko) 벤즈아미드 유도체
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
KR930006003A (ko) 이미다졸릴메틸-피리딘류 화합물
KR860003247A (ko) 티아디아진 화합물 및 그 염의 제조방법
KR910005860A (ko) 항간질환성 조성물
KR900009640A (ko) 벤족 사제핀 유도체
KR910000638A (ko) 피롤카르복시산 유도체

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid